Silentius

Company Overview

Snapshot

Founded in July 2025, Silentius operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its objective tinnitus measurement and personalized relief technology.

Business overview

Silentius is developing a platform for tinnitus care within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Medical Diagnostics. The company's core technology involves proprietary algorithms combined with neuro-auditory technology to objectively measure patient-specific tinnitus parameters. This enables the delivery of personalized countermeasure signals designed to reduce symptoms. Silentius integrates hardware and software for a drug-free, non-invasive solution, aiming to replace subjective self-reporting with measurable characterization for more precise diagnosis and individualized treatment approaches for clinical and patient needs. The company operates on a B2B business model.

Company Intelligence Q&A

What is Silentius's primary focus?

Silentius is focused on developing a platform for objective tinnitus measurement and personalized, non-invasive relief technology within the Health Tech & Life Sciences sector.

When was Silentius founded?

Silentius was founded in July 2025.

What is the current employee size of Silentius?

Silentius currently has 1–10 employees.

What is Silentius's business model?

Silentius operates on a B2B business model, targeting clinical and patient needs with its tinnitus care platform.

What problem does Silentius aim to solve in tinnitus care?

Silentius aims to replace subjective self-reporting in tinnitus diagnosis with objective, measurable characterization, enabling more precise diagnosis and individualized treatment approaches through its proprietary technology.